Associations Between Statin Use and Risk of Non-Hodgkin Lymphomas by Subtype

International Journal of Cancer - United States
doi 10.1002/ijc.31373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Constitutive Overexpression of a Novel 21 kDa Protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2008English

Statin Use and Prognosis in 12,865 Non-Hodgkin Lymphoma Patients Treated in the Rituximab-Era

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Associations Between Exhaust and Non-Exhaust Particulate Matter and Stroke Incidence by Stroke Subtype in South London

Science of the Total Environment
DisposalEnvironmental ChemistryWaste ManagementEnvironmental EngineeringPollution
2016English

Recreational Amphetamine Use and Risk of HIV-related Non-Hodgkin Lymphoma

Cancer Causes and Control
Cancer ResearchOncology
2008English

Pesticide Product Use and Risk of Non-Hodgkin Lymphoma in Women

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2004English

Statin Use and Risk of Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Brentuximab Vedotin for Treatment of Non-Hodgkin Lymphomas: A Systematic Review

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2017English

Comparison of Efficacy of Pembrolizumab Between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Statin Use and Risk of Basal Cell Carcinoma

Journal of the American Academy of Dermatology
Dermatology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy